To better understand the mechanisms by which neurotropic viruses invade peripheral nerve pathways and produce CNS disease, we defined the type 3 (T3) reovirus genes that are determinants of the capacity of reovirus T3 strain Dearing (T3D) and T3 clone 9 (C9) to infect the spinal cord and kill mice after hindlimb injection. T3D and C9 viruses are both highly virulent (LD 50 Ͻ 10 1 PFU) after intracranial injection of neonatal mice. However, C9 is significantly more lethal than T3D after either intramuscular injection (LD 50 Ͻ 10 1 vs LD 50 10 4 PFU) or peroral injection (LD 50 10 3.4 vs LD 50 Ͼ 10 8.3 PFU). Using reassortant viruses containing different combinations of genes derived from T3D and C9, we found that the S1 gene, encoding the cell attachment protein sigma 1 and the nonstructural protein sigma 1s, and the L3 gene, encoding the core shell protein lambda 1 were the primary determinants of lethality after intramuscular injection. The L3 gene and the L2 gene encoding spike protein, lambda 2, determined differences in spinal cord titer after intramuscular injection. A C9 ϫ T3D mono-reassortant containing all T3D genes except for the C9-derived L3 was lethal after peroral injection. These studies indicate that the S1, L2, and L3 genes all play a potential role in neuroinvasiveness and provide the first identification of a role in pathogenesis for the L3 gene.
INTRODUCTION
The central nervous system (CNS) is partially protected from systemic infections by the blood-brain barrier. Neurotropic viruses employ several strategies to penetrate this defense and produce neurological disease (Mims, 1987) . Bloodborne viruses may invade neural tissue after infecting vessels in the brain or spinal cord or may spread to neural sites through the cerebrospinal fluid (CSF) by crossing the blood-(CSF) junction in the meninges or choroid plexus. Neurally spreading viruses can evade the blood-brain barrier by utilizing peripheral nerve fibers as direct pathways into the CNS. Rabies virus, poliovirus, herpes simplex virus, and reovirus travel via the fast axonal transport system in motor, sensory, or autonomic fibers to spread through the nervous system from extraneural sites of infection (Nathanson and Tyler, 1997) .
Reovirus infection of neonatal mice has provided an important animal model for studying the pathogenesis of virus-induced CNS disease. Different reovirus serotypes have been identified based on neutralization and hemagglutination-inhibition assays (Nibert and Schiff, 2001) , and viruses belonging to these serotypes differ in their pattern of CNS infection. Serotype 1 reoviruses primarily spread to the CNS by hematogenous routes, infect ependymal cells, and produce a generally nonlethal ependymitis (Tyler and Fields, 1996) . However, after intramuscular or peroral injection serotype 3 viruses utilize peripheral nerve pathways to invade the CNS, infect neurons, and produce lethal encephalitis Morrison et al., 1991) . Because reoviruses contain 10 segments of dsRNA, most encoding a single major protein, reassortant viruses may be generated from parents exhibiting unique patterns of disease (Nibert and Schift, 2001) . Analysis of the pathogenesis of reassortant viruses after intracranial injection (IC) has shown that the major product of the S1 gene, virus cell attachment protein, sigma 1, determines tropism for neurons or ependymal cells by serotype 3 and serotype 1 viruses, respectively (Weiner et al., 1977) . Among serotype 3 strains, the product of the M2 gene, a major outer capsid structural protein, mu 1, influences differences in the capacity of these viruses to grow in the brain (Hrdy et al., 1982) . Thus, at least two reovirus genes play distinct roles in determining neurovirulence after IC injection.
After hindlimb injection, type 3 reovirus travels to the spinal cord via the sciatic nerve . Viruses are carried to the spinal cord by fast axonal transport and within 14 h viral antigens are detected in spinal cord motor neurons ipsilateral to the injection site (Flamand et al., 1991) . To identify genes that influence type 3 reovirus neuroinvasiveness, we first identified two neurotropic type 3 viruses that differ in lethality when injected into the hindlimb but not after injection into the brain. We reasoned that such viruses might differ at early steps in pathogenesis (primary replication and/or spread to the nervous system), yet be similar at later steps (tropism and growth in the brain). By analysis of the pathogenesis of reassortant viruses generated from these viruses, we identified reovirus genes important for type 3 reovirus invasion of the central nervous system after peripheral injection.
RESULTS

Characterization of reassortant viruses
In 1-day old mice, we found that two type 3 reoviruses, strain Dearing (T3D) and clone 9 (C9), had similar 50% lethal doses (LD 50 ) by the intracranial (IC) route of injection (LD 50 Ͻ 5 plaque-forming units (PFU)/mouse). However, 1000 times more T3D than C9 virus was required for an LD 50 after intramuscular (IM) injection (LD 50 for T3D Ͼ 10 4 vs LD 50 for C9 Ͻ 10 1 ). To determine the genetic basis for this difference in neuroinvasiveness, we characterized a panel of T3D ϫ C9 reassortant viruses generated by coinfection of murine L929 cells (Table 1) . Viral genotypes were defined by analysis of the migration patterns of the dsRNA gene segments in polyacrylamide gels. As reported previously for intertypic (Type 1 ϫ Type 3) reovirus reassortants (Nibert et al., 1996) , we found a nonrandom distribution of certain genes in the intratypic T3D ϫ C9 reassortants. The M1 and M2 genes cosegregated in all reassortants and the T3D L2 gene was present in all but two reassortants.
Genetic determinants of lethality after im injection
To identify the gene(s) associated with route-specific lethality differences, we determined the LD 50 of each reassortant after hindlimb injection of 1-day old mice. Three to five dilutions of each of the 32 viruses were injected into groups of four to six mice (total 768 mice). The resulting LD 50 s exhibited a range of values (lethal viruses having the lowest LD 50 ), with no clear gap between more and less lethal groups (Table 1) . No reassortant was more lethal than the parental C9; however, several were less lethal than T3D. Statistical analysis demonstrated a significant association between lethality and the derivation of the S1 (MW test, P ϭ 0.002; t test, P ϭ 0.001) and the L3 (MW test, P ϭ 0.016; t test, P ϭ 0.016) genes and a possible but less significant association between lethality and the S2 gene (MW test, P ϭ 0.03; t test, P ϭ 0.4). To calculate the influence on lethality of individual C9 genes in the context of all other genes, we subjected the data to linear regression analysis with each gene an independent variable, except for the cosegregating genes, M1 and M2, which were treated as a single variable (Fig. 1) . Two C9 genes were associated with significant increases in virus lethality. The presence of a C9-derived L3 gene was associated with an approximate reduction in LD 50 of 1.8 log (P ϭ 0.001), while the presence of a C9-derived S1 gene reduced LD 50 by 1.6 log (P ϭ 0.001). Conversely, the presence of a C9-derived M1/M2 gene pair tended to make reassortants less lethal, increasing LD 50 by about 1 log (P ϭ 0.03). The regression equation accounted for 67% of the variance seen in the data (R 2 ϭ 0.67, P ϭ 0.001, where R 2 , the square of the multiple correlation, represents the proportion of the variance in the depen- 
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b Lethality expressed as median lethal dose (LD 50 ) in log 10 PFU/ mouse. c Titer of virus in spinal cord on day 5 postinoculation (log 10 PFU/ml). d Percentage of injected animals surviving after peroral injection. dent variable accounted for by the independent variables). Taken together, these results suggested that the difference in T3D and C9 lethality after skeletal muscle injection was multigenic, i.e., the C9 L3 and S1 genes increased virus lethality, while the C9 M1 and/or M2 gene(s) tended to decrease lethality. Because the substitution of certain C9 genes increased T3D lethality after IM injection, we analyzed separately the subset of viruses carrying the T3D S1 gene (Table 2 ). All viruses more lethal than T3D contained the C9 L3 gene, and the most lethal virus was mono-reassortant 2.11, with an LD 50 2.3 log lower than that of T3D. Conversely, all reassortants containing the C9 M1/M2 gene pair were less lethal than T3D. In those reassortants with both the C9 L3 and the C9 M1/M2 genes, the M1/M2 decrease in lethality was dominant. Thus while the association between lethality and the derivation of the M1/M2 gene pair (MW test, P ϭ 0.015; t test, P ϭ 0.012) was statistically significant in this set of reassortants, the association between lethality and the derivation of the L3 gene was not (MW test, 0.058; t test, P ϭ 0.055). However, regression analysis, which identifies the contribution of each variable while allowing for the contribution of the other independent variables, suggested that the C9 L3 gene was associated with increased lethality (LD 50 reduced by 1.5 log, P ϭ 0.02), while the C9 M1/M2 decreased lethality (LD 50 increased by 1.8 log, P ϭ 0.01). The regression equation accounted for 85% (P ϭ 0.03) of the variance in LD 50 . Thus, while substitution of the C9 L3 gene increased T3D lethality, the C9 M1/M2 pair had an opposite, and dominant, effect.
Lethality after peroral injection
C9 reovirus is lethal after peroral (PO) injection while T3D is not (Rubin and Fields, 1980; Morrison et al., 1991; Tyler et al., 1989) ; however, the genetic basis of this difference has not been identified. To determine whether the reassortants shown to be more lethal after skeletal FIG. 1. Contribution of individual C9 genes to virus lethality. Each bar represents the difference in LD 50 contributed by a single gene in association with all other genes after im injection of T3D ϫ C9 reassortants in 1-day old mice. **P ϭ 0.0008; *P ϭ 0.001.
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b Parental origin of gene segment: 3, gene derived from T3D: 9, gene derived from C9. muscle injection were also more lethal after peroral injection, we injected groups of four to five 1-day old mice with each reassortant (135 mice) at a dose at which C9 killed 100% of injected mice while T3D killed few mice. Results were calculated as percentage survival and compared with LD 50 after IM injection (Table 1) . As was seen after IM injection, reassortants carrying the C9 S1 gene tended to be most virulent after PO injection. However, two viruses carrying the T3D S1 gene killed more than 50% of the mice: 2.11, the mono-reassortant carrying the C9 L3 gene, and 1.118, carrying the C9 L3, S3, and S4 genes. These also were the T3D reassortants most virulent after IM injection. To quantify this result, PO LD 50 s were calculated for these two reassortants, as well as for T3D and C9 (Table 3 ). LD 50 s were 3.4, 6.3, and 6.4 log 10 PFU per mouse for C9, 2.11, and 1.118, respectively. However, the highest dose of T3D (8.3 log 10 PFU) was insufficient for an LD 50 . Thus, substitution of the C9 L3 gene alone was sufficient to confer lethality after peroral injection to T3D, a virus normally avirulent by this route.
Spinal cord infection after IM injection
Ventral spinal cord neurons ipsilateral to the injection site are the first site of virus replication in the CNS after hindlimb injection Flamand et al., 1991) . To determine whether T3D and C9 differed in their capacity for spinal cord infection after IM injection, we injected groups of 1-day old mice with 10 2 PFU of virus, a dose expected to kill all C9-and a few T3D-infected pups. Viral titer was measured in muscle, spinal cord, and brain tissue collected on alternate days after injection ( Figs. 2A and 2B ). Both viruses replicated well in muscle, suggesting that differences in the capacity of these viruses to replicate in skeletal muscle were not responsible for differences in neuroinvasiveness or lethality. In contrast, by 5 days postinjection there was a 4 log difference between T3D and C9 titers in spinal cord and brain. This suggested that there was a difference in either the capacity of these viruses to spread or the capacity to replicate within the spinal cord. To distinguish between these possibilities, and because direct spinal cord injection of virus was not feasible in newborn mice, we injected 1-day-old mice in the hindlimb with a 100 times larger dose of each virus (10 4 PFU) than was used in our initial experiments. This dose of virus produced measurable spinal cord titers by 24 h postinjection (Fig. 2C ), suggesting that if there is a defect in spread it is relative rather than absolute. At this dose, T3D and C9 grew at a similar rate over the first 5 days after injection. However, at each time point, the titer of T3D was about 10-fold less than that of C9. These results suggested either that T3D might be less efficient than C9 in the initiation of spinal cord infection, that is, while both grew well once infection was established, higher doses of T3D were required to produce comparable spinal cord titers, or that less virus was produced per infected cell.
To identify the gene(s) responsible for differences in 
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b Parental origin of gene segment: 3, gene derived from T3D: 9, gene derived from C9. T3D and C9 spinal cord infection, we measured viral titers in spinal cord tissue collected 5 days after hindlimb injection of three to six 1-day-old mice with 10 2 PFU of each reassortant (total 195 mice). This time point had shown clear differences between T3D and C9 spinal cord titers but lower standard deviations than Day 3 (Fig.  2) . The panel of reassortants produced a range of titers (Table 1) . C9 produced the highest titer, while T3D fell midway between C9 and reassortants producing no detectable spinal cord titer at Day 5. Reassortants with the highest titers tended to carry the C9 L3 gene. Statistical analysis demonstrated a significant association between spinal cord titer and the derivation of the L3 (MW test, P ϭ 0.028, t test, P ϭ 0.033) and L2 (MW test, P ϭ 0.018, t test, P ϭ 0.004) genes. Because few reassortants carried the L2 gene, additional reassortants will be required to confirm this result. However, the behavior of the C9 mono-reassortant carrying the T3D L2 gene (spinal cord titer 3.9 logs lower than C9) supported a role for the L2 gene in spinal cord infection. Although the S1 gene was implicated in lethality, it was not associated with differences in spinal cord infection. To determine the influence of individual genes on Day 5 spinal cord titers, we subjected the data to linear regression analysis (Fig. 3) . The C9 L2 gene increased spinal cord titer by 3.2 log (P ϭ 0.001). The C9 L3 gene increased titer by 2.0 log (P ϭ 0.001). The regression equation accounted for 59% of the variation seen in the data (R 2 ϭ 0.59, P ϭ 0.007). Thus, after IM injection, the L3 gene influenced spinal cord infection, as it had virus lethality. The correlation between Day 5 spinal cord titer and virus lethality was significant (Spearmann rank correlation, P ϭ 0.005; simple regression, P ϭ 0.001) but accounted for only 31% of the variance. Thus, spread to the spinal cord after IM injection, as measured by Day 5 virus titer, was a weak predictor of reassortant lethality.
DISCUSSION
The neurotropic type 3 reoviruses use peripheral nerve fibers to invade the CNS from extraneural sites of infection Morrison et al., 1991) . Field isolates, T3D and C9, are highly virulent after intracranial injection of neonatal mice; however, C9 is significantly more lethal than T3D after intramuscular injection. To better understand the mechanisms by which viruses invade peripheral nerve pathways to produce CNS disease, we used reassortant viruses to identify virus genes important for differences in type 3 reovirus neuroinvasion following inoculation at different sites in the mouse.
Nonrandom segregation of T3D ϫ C9 genes
This article is the first characterization and usage of T3D ϫ C9 intratypic reassortants to identify differences in neuroinvasion between type 3 viruses with similar tropism and neurovirulence. In the panel of reassortants we found that certain genes cosegregated (M1 and M2) or were underrepresented (C9 L2). In addition, none of the T3D reassortants (carrying T3D S1) incorporated the C9 S2 gene. Nonrandom distribution of reovirus gene segments has been reported previously for intertypic serotype 1, Lang (T1L) ϫ serotype 3 (T3D) reovirus reassortants (Nibert et al., 1996) . As in our T3D ϫ C9 reassortants, the T3D L2 gene was found in most of the intertypic reassortants, and the T3D L3 and T3D S4 genes were somewhat underrepresented. Interestingly, in our panel, the two reassortants carrying the C9 L2 gene had the same genotype except for the S1 gene. Thus, a specific interaction between lambda 2 and one or more C9 proteins other than, or in addition to, sigma 1 may be necessary to produce a viable reassortant. An increased frequency of homologous pairing of certain parental alleles was reported for the T1L ϫ T3D reassortants, but not of M1 and M2, and, in no case did the parental alleles invariably cosegregate. The mechanisms responsible for the nonrandom nature of reovirus reassortment are unknown. Evidence for structural and/or functional interactions between reovirus proteins has been demonstrated by extragenic suppression of temperature-sensitive phenotypes (McPhillips and Ramig, 1984) and by identification of serotype-associated patterns of monoclonal antibody binding to outer capsid reovirus proteins (Virgin et al., 1991) .
Lethality after IM injection
Two genes, S1 and L3, were primarily associated with lethality differences between T3D and C9 after hindlimb injection. The S1 gene, encoding the viral cell attachment protein, sigma 1, defines reovirus serotype and is responsible for serotype-specific differences in disease phenotype after intracranial injection (Weiner et al., 1980) . Type 1 reovirus infection produces a generally nonlethal ependymitis, while type 3 infection produces a lethal encephalitis (Tyler and Fields, 1996) . Thus, an association of S1 with differences in reassortant lethality is not surprising. Previous associations of the S1 gene with differences in neuroinvasion using intertypic T1L ϫ T3D reassortants Bodkin and Fields, 1989) , reassortants made using T3D and an immune selected variant (Kaye et al., 1986) , and variants selected in severe combined immunodeficient (SCID) mice (Haller et al., 1995) , all correlated with differences in virulence after intracranial injection. However, the difference between T3D and C9 lethality after IM injection was not associated with a difference in lethality after IC inoculation. After IC injection, the LD 50 values for both T3D and C9 are less than 10 PFU/mouse. Thus, the present identification of the S1 gene contribution to lethality after hindlimb injection suggests additional roles of the sigma 1 protein that are specific to the routes of neuroinvasion studied here.
The reovirus L3 gene was a determinant of reovirus lethality for the IM, as well as the PO (see below), routes. The L3 gene product, lambda 1, is the major structural component of the inner shell of the viral capsid, which organizes the packing of the genomic RNA. Lambda 1 is believed to act as a helicase during transcription by the lambda 3 protein (Reinisch et al., 2000; Bisaillon et al., 1997; Noble and Nibert, 1997) . Differences in the lambda 1 protein may affect the stability of the virus core, a multienzyme protein shell which must remain intact during virus uncoating and transcription of single-stranded RNA and/or may affect enzymatic activities required for viral transcription in different cell types. Strain-specific differences in the ATPase activities associated with the lambda 1 protein have been found in vitro, but T3D and C9 have not been compared (Noble and Nibert, 1997) . Genes encoding core proteins, including L3, have been shown to influence virus growth in cultured mouse heart cells (Matoba et al., 1991) . However, no in vivo phenotype had been mapped to the L3 gene previously.
The M1 and/or M2 gene(s) also contributed to differences in T3D and C9 lethality and had the opposite effect of S1 and L3. The M1 gene encodes inner capsid protein, mu 2, an NTPase with RNA-binding activity that forms part of the virus transcription complex (Brentano et al., 1998) . Reassortant analysis has linked a group of genes, including M1, with virus induction of myocarditis in newborn mice (Sherry and Blum, 1994) and with the extent of replication in cultured mouse heart cells and bovine aortic endothelial cells (Matoba et al., 1993) . The M2 gene encodes a major outer capsid protein, mu 1. The M2 gene has been shown to influence neurovirulence among Type 3 strains when injected into the brain of newborn mice (Hrdy et al., 1982) . Growth in the CNS and virulence was decreased in virus T3H/Ta (now T3 clone 8), a phenotype that mapped to the M2 gene. Interestingly, a close relationship between the type 3 M1 and M2 genes has been suggested by the extragenic suppression of M2 attenuation by the M1 gene and restoration of T3, clone 8 virulence (Jayasuriya, 1991) .
Lethality after PO injection
In addition to demonstrating a role for the lambda 1 protein in neuroinvasion after skeletal muscle injection, we also found that the C9 L3 gene confers lethality to T3D after peroral injection, the natural route of reovirus infection. T3D avirulence has been attributed to the sigma 1 protein, which is sensitive to cleavage by proteases and is associated with reduced virus growth in the intestine (Bodkin and Fields, 1989; Nibert et al., 1995) . However, in our reassortants, a single C9 gene, L3, was sufficient to confer lethality after PO injection to a T3D mono-reassortant carrying the protease-sensitive T3D sigma 1 protein. Because the lambda 1 protein is located in the inner capsid, this result is not likely the result of a steric protection of the sigma 1 cleavage site, as has been suggested for the lambda 2 spike protein (Bodkin and Fields, 1989) . However, the lambda 1, lambda 2, lambda 3, and sigma 1 proteins together comprise the structurally dynamic vertex of the viral capsid where cell binding, viral transcription, and extrusion of mRNA are localized. Thus a change in one protein in the complex may affect the function of another. A contribution of genes other than S1 to T3D lethality after PO injection was also suggested in previous studies by Chappell et al. (1997) . The sigma 1 protein of a T3D variant isolated from SCID mice revealed a single amino acid change associated with resistance to protease cleavage. Compared to T3D, this virus showed increased growth in intestine but decreased growth in the brain in SCID mice. In neonatal mice, growth in intestine and the spread to the brain after PO injection were increased, but growth in the brain and virulence were decreased after IM injection.
Spinal cord infection after IM injection
At low doses, T3D appeared to infect the CNS more slowly than C9 after hindlimb injection. However, when tested at higher doses, the rate of virus growth in the spinal cord was similar for both T3D and C9, but 10-fold more infectious virus particles were required to produce similar titers. Other studies suggest that T3D and C9 are both rapidly transported to the neural soma, producing antigen-positive neurons 14-15 h after hindlimb injection (Flamand et al., 1991; Mann et al., 2002) . Thus T3D and C9 may differ in efficiency of invasion of neonatal nerve terminals, or at an early step in replication in motor neurons.
The difference in Day 5 spinal cord titer was associated with the L3, and possibly the L2, gene. Together, the L3 and L2 genes have been associated previously with differences in virus growth in cardiac cell cultures (Matoba et al., 1991) . Pentameric complexes of the L2 product, lambda 2, form hollow spikes through which internally transcribed mRNA exits the viral particle (Nibert and Schift, 2001) . Because lambda 2 anchors sigma 1 in the outer capsid and caps nascent mRNAs as they exit the inner core (Reinisch et al., 2000) , this protein may influence the efficiency and/or stability of the capsid during binding, uptake, and targeting to endosomes, as well as the production of viral mRNA and its delivery to the host cytoplasm. The L2 gene has been previously associated genetically with differences in the efficiency of reovirus horizontal spread between infected and uninfected littermates (Keroack and Fields, 1986) and in association with the S1 and M1 genes with differences in reovirus growth in the intestine early in PO infection (Bodkin and Fields, 1989) . In association with the M1 gene, the L2 gene has been associated genetically with induction of myocarditis (Sherry and Blum, 1994) .
Lethality and spinal cord infection
The set of genes determining differences in viral titers in Day 5 spinal cord after IM injection was somewhat different from that determining lethality differences by the same route. The L2 gene appeared to be the stronger determinant of spinal cord infection, yet did not significantly affect virus lethality. Conversely, the S1 gene was the stronger determinant of lethality after IM injection, yet had no significant effect on differences in spinal cord titers. The M1/M2 gene pair also influenced lethality but not spinal cord invasion. Only the L3 gene influenced both lethality and spinal cord infection and was sufficient to rescue T3D lethality after PO injection. However, after im injection, the paired contribution of S1 and L3 to lethality and of L2 and L3 to spread outweighed the independent contribution of L3 to each, and in the subset of T3D reassortants, the decrease in lethality associated with the C9 M1/M2 genes negated the increase associated with L3. Functional interdependence among type 3 proteins is suggested by the nonrandom reassortment of T3D and C9 genes (see above). In addition, the identification of serotype-specific sets of reovirus genes suggests that structure/function relationships evolve in association with particular virus strains (Virgin et al., 1991) .
The correlation between Day 5 spinal cord titer and reassortant lethality was statistically significant but low. Thus, these may reflect independent properties of type 3 reovirus neuroinvasiveness. For example, virus spread from spinal cord to brain may occur soon after infection of motor neurons and thus is not directly related to subsequent growth in the spinal cord. Alternatively, for some reassortants, early replication in the spinal cord may be dampened by Day 5 and thus would not be detected in our study, or some reassortants may better utilize other pathways to infect the brain; for example, certain gene combinations may facilitate bloodborne spread. T3D and C9 also differ in their induction of apoptosis (Tyler, in press) , and this mechanism is independent of virus growth. Further experiments are needed to determine the contributions of these mechanisms to spinal cord infection and lethality.
Virus genes determining neuroinvasion after IM injection have been identified in the herpes simplex virus. Two viruses, nonlethal ANG and a lethal mouse brainpassage derivative, ANGpath, showed similar virulence after IC injection of adult mice (LD 50 ϳ 1 PFU), yet differed in neuroinvasiveness (LD 50 10 5 vs Ͼ10 8 ) after hindlimb injection (Izumi and Stevens, 1990) . This difference correlated with restricted entry into the nervous system after footpad injection and mapped to the gene encoding glycoprotein D (gD), an envelope glycoprotein required for postattachment binding to a coreceptor. Because replacement of the ANG gD with ANGpath gD did not fully rescue ANGpath gD ϫ ANG recombinant viruses to ANGpath LD 50 levels, other genes may also be involved.
Taken together, our results suggest that both inner and outer capsid proteins influence reovirus neuroinvasiveness. In combination with sigma 1 and mu 1 and/or mu 2, inner capsid protein lambda 1 influences virus lethality, and with lambda 2, influences spinal cord infection after IM injection. Lambda 1 also can increase the lethality of T3D by the natural route of infection.
MATERIALS AND METHODS
Cells
Spinner-adapted mouse L929 (L) cells (ATCC) were grown in suspension or monolayer cultures in Joklik's modified Eagle's minimal essential medium (MEM, Irvine Scientific) supplemented with 5% fetal bovine serum (HyClone Laboratories) and 2 mM L-glutamine, 1 U penicillin, and 1 g streptomycin (Irvine Scientific) per milliliter.
Viruses
Reovirus type 3, strain Dearing (T3D), and clone 9 (C9) were laboratory stocks described previously (Tyler et al., 1989; Hrdy et al., 1979) . T3D ϫ C9 reassortant viruses were grown from stocks originally isolated by Ken Tyler and Dinah Bodkin in our laboratory. Viruses were doubly plaque purified and passaged in L cells to generate working stocks as described previously (Tyler et al., 1985) . T3D and C9 viruses were purified from infected L cell lysates by cesium chloride gradient centrifugation (Furlong et al., 1988) .
Animals and inoculations
One-day-old Swiss Webster (Taconic) or NIH Swiss (National Cancer Institute) mice received intracerebral inoculations (IC) into the right hemisphere or IM into the left hindlimb with a Hamilton syringe and 30-gauge needle. Tissue samples were collected in gelatin-saline (phosphate-buffered saline, 0.3% gelatin) and stored at Ϫ80°C until used for viral titration. To determine virus lethality, at least three groups of mice (five to six mice per group) were inoculated by the IC or IM route with serial dilutions of each virus and monitored daily for signs of morbidity. Experiments were terminated at 21 days postinfection, and 50% lethal doses (LD 50 ) were calculated by the method of Reed and Muench (Reed and Muench, 1938) .
Characterization or reassortants
L cell monolayers were infected with 10 PFU of virus stock per cell, and cytoplasmic extracts were prepared for polyacrylamide gel analysis (Tyler et al., 1985) . To resolve certain gene segments, 6 or 10% gels were run on long (30 cm) gel plates. To identify the parental origin of closely migrating gene segments, samples were double-loaded into wells with T3D or C9 dsRNA.
Determination of viral titer
Tissue samples were frozen and thawed three times and then sonicated for 30 s using a microtip probe to homogenize the tissue. L cell monolayers in six-well plates (10 6 cells per well) were inoculated in duplicate with serial 10-fold virus dilutions (Tyler et al., 1985) .
Statistical analysis
The effect of the derivation of individual reovirus gene segments was analyzed by nonparametric (Mann-Whitney) and parametric (t test and multiple regression analysis) statistical tests (Virgin et al., 1997; Tyler et al., 1996) . Correlation was calculated by Spearmann (nonparametric) and regression (parametric) analysis. Statistical tests were performed using Stat-View software (Abacus Concepts, Berkley, CA).
